SOAT1 and acute lymphoblastic leukemia: In oncology research, Rutherford et al. identified that AMPK activation inhibited acute lymphoblastic leukemia by blocking the JAK/STAT signaling pathway through the inhibition of WT or JAK1V658F [37].